Black Rock Inc. Athira Pharma, Inc. Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ATHA
# of Institutions
43Shares Held
15.2MCall Options Held
24.1KPut Options Held
0-
Perceptive Advisors LLC New York, NY5.4MShares$21 Million0.07% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.23MShares$12.5 Million0.74% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.49MShares$5.79 Million0.55% of portfolio
-
Tang Capital Management LLC San Diego, CA600KShares$2.33 Million0.01% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ425KShares$1.65 Million0.01% of portfolio
About Athira Pharma, Inc.
- Ticker ATHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,817,700
- Market Cap $147M
- Description
- Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...